Skip to main content

How I went from WOW to OH, to OMG to RESPECT on my first meeting with Diabetes Action Canada

By: Patrice Bleau, Type 1 Diabetes for 35 years The Patient-Oriented Research training that took place October 31st and November 1st at the Alberta Diabetes Institute was my first face-to-face involvement with Diabetes Action Canada. Being a new patient partner with Diabetes Action Canada I was expecting this training to provide basic information to better […]

Featured Member- André Carpentier

Dr. Carpentier is the co-director of Diabetes Action Canada Training and Mentoring Goal Group and the recipient of the GSK Research Chair in Diabetes of Université de Sherbrooke, professor and endocrinologist-lipidologist in the Departments of Medicine, Faculty of Medicine at the Université de Sherbrooke. He is also the director of the university’s Centre de recherche […]

CIHR and JDRF join forces to focus on the needs of individuals with Type-1 Diabetes

November was an extremely busy time for the Clinical Trials and New Therapies Goal Group. On the tail end of the Diabetes Canada Conference and on World Diabetes Day – November 14th, 2017 – the CIHR/JDRF iCT multi-year operating grant application was due.   Eight letters of intent were selected for this competition, with four applications […]

People living with diabetes speak. Diabetes Action Canada listens!

What topics are most important to people living with or caring for someone living with diabetes?  This vital question was asked by Diabetes Action Canada investigators, Drs. Joyce Dogba, France Légaré, Holly Witteman and colleagues in a study published yesterday in Health Expectations. This study outlines methods for collecting valuable insight into what research topics […]

FEATURED MEMBER

Michelle Murray holds a Master’s degree in Public Administration and a Bachelor’s degree in Education from the Université de Moncton. After teaching for seven years, she worked as a project coordinator at the Université de Moncton and the Société Santé et Mieux-être en français du Nouveau-Brunswick. Prior to her appointment as the coordinator for the […]

Message from the Co-Scientific Leads – Our Goal Groups in Action

        It is an exciting time to be part of Diabetes Action Canada.  We have now been in operation for almost a year and a half and already we are starting to see meaningful contributions to improving the lives of those living with diabetes.  So far we have organized ourselves into eight […]

Training and Mentoring Goal Group

    The Training and Mentoring Goal Group of Diabetes Action Canada aims to strengthen patient-oriented research capacity for diabetes and its complications in Canada. This Goal Group focuses on preparing the next generation of diabetes researchers across Canada in Patient-Oriented Research methods pertaining to all CIHR pillars. The Training and Mentoring Goal Group develops […]

MARITIME SPOR SUMMIT

On December 4 and 5, 2017, the inaugural Maritime SPOR Summit will take place in Halifax, Nova Scotia. Building on the success of the New Brunswick SPOR Summit held in June 2017, the Summit will promote increased collaboration between the Maritime SPOR networks in ongoing research, priorities, and future initiatives. Participants will have the opportunity […]

Congratulations France Légaré for making the 2017 Highly Cited Research List!

  Diabetes Action Canada is proud to announce that Dr. France Légaré, Co-Principal Investigator for our Knowledge Translation Goal Group, has made the 2017 Highly Cited Researcher List! Ranked in the top 1% by citation for field and publication year in Web of Science for 2017, Highly Cited Researchers are leading the way in solving […]

SPOR Evidence Alliance Launches it’s Integrated Knowledge Translation Approach

  The SPOR Evidence Alliance (hereafter, the Alliance) is developed out of Li Ka Shing Knowledge Institute at St. Michael’s Hospital. The vision of the Alliance is to create a rapid learning health system where patients receive the right intervention at the right time by facilitating access to high-quality evidence and accelerating its use in […]